Evidence map›Paper›PMID 17091221›Full record

ArticleJournal of human genetics2007

Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assay.

Valentina Gatta, Ivana Antonucci, Elisena Morizio, Chiara Palka, Rita Fischetto, Vahe Mokini, Stefano Tumini, Giuseppe Calabrese, Liborio Stuppia

Open access · bronzeAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Valentina GattaDepartment of Biomedical Sciences and Aging Research Center, Ce.S.I., G. d'Annunzio University Foundation, Via dei Vestini 35, Chieti-Pescara, 66013, Italy.
Ivana AntonucciDepartment of Biomedical Sciences and Aging Research Center, Ce.S.I., G. d'Annunzio University Foundation, Via dei Vestini 35, Chieti-Pescara, 66013, Italy.
Elisena MorizioService of Human Genetics, Pescara Hospital, Pescara, Italy.
Chiara PalkaIRCCS-CSS San Giovanni Rotondo and CSS-Mendel Rome, Rome, Italy.
Rita FischettoAzienda Ospedaliera ''Di Venere'' e ''Giovanni XXIII'', Sezione di Genetica Medica, Bari, Italy.
Vahe MokiniService of Medical Genetics, University Hospital Center "Mother Theresa", Tirana, Albania.
Stefano TuminiDipartimento di Pediatria e Ginecologia, Università "G D'Annunzio", Chieti, Italy.
Giuseppe CalabreseDepartment of Biomedical Sciences and Aging Research Center, Ce.S.I., G. d'Annunzio University Foundation, Via dei Vestini 35, Chieti-Pescara, 66013, Italy.
Liborio StuppiaDepartment of Biomedical Sciences and Aging Research Center, Ce.S.I., G. d'Annunzio University Foundation, Via dei Vestini 35, Chieti-Pescara, 66013, Italy. stuppia@unich.it.
University of Chieti-Pescara · ITAzienda USL di Pescara · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITMother Teresa Hospital · ALOspedale Pediatrico Giovanni XXIII · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deletions of the SHOX gene (Xp22-Yp11.3) are associated with Leri-Weill dyschondrosteosys (LWD) and idiopathic short stature. It has been estimated that SHOX deletions occur in 1,000-2,000 individuals in the total population, suggesting that this alteration should be investigated in all cases with unexplained short stature. SHOX deletions are currently investigated using fluorescence in situ hybridization (FISH) or molecular analysis of intragenic CA repeats. However, both techniques show some limitations. In the present study, the use of the multiple ligation probe amplification (MLPA) assay for the identification and characterization of SHOX deletions in 15 LWD patients, 3 of which carriers of chromosome abnormalities involving the SHOX gene, is reported. MLPA analysis demonstrated the heterozygous deletion of SHOX in seven patients (46.6%), disclosing the presence of two different proximal breakpoints. In patients with abnormal karyotype, MLPA analysis was able to identify the chromosomal rearrangement, showing, in addition to the SHOX deletions, the gain or loss of other genes mapped on the X and Y chromosomes. Since MLPA analysis can be carried out on a simple buccal swab, avoiding invasive peripheral blood collection, this technique represents a fast, simple and high throughput approach in the screening of SHOX deletions, able to provide more information as compared to FISH and microsatellite analysis.

Indexed as

Gene DeletionAbnormalities, MultipleAdolescentAdultChildChromosomes, Human, XDwarfismFemaleGrowth DisordersHomeodomain ProteinsHumansMaleOsteochondrodysplasiasPolymerase Chain ReactionShort Stature Homeobox ProteinHomeodomain ProteinsShort Stature Homeobox ProteinSHOX protein, human

Identifiers

PMID17091221
OpenAlexW1986372960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.